高级检索
当前位置: 首页 > 详情页

Seven protective miRNA signatures for prognosis of cervical cancer

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Wuhan Univ, Sch Publ Hlth, Wuhan 430071, Peoples R China [2]Taizhou Hosp, Dept Anesthesiol, Taizhou 317000, Peoples R China [3]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Geriatr Med, Wuhan 430030, Peoples R China [4]Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Clin Oncol, Canc Epigenet Lab, Hong Kong 999077, Hong Kong, Peoples R China [5]Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong 999077, Hong Kong, Peoples R China [6]Hubei Univ Chinese Med, Dept Nursing, Wuhan 430063, Peoples R China
出处:

关键词: cervical cancer survival analysis Cox's model GO enrichment pathway analysis

摘要:
Cervical cancer is the second cause of cancer death in females in their 20s and 30s, but there were limited studies about its prognosis. This study aims to identify miRNA related to prognosis and study their functions. TCGA data of patients with cervical cancer were used to build univariate Cox's model with single clinical parameter or miRNA expression level. Multivariate Cox's model was built using both clinical information and miRNA expression levels. At last, STRING was used to enrich gene ontology or pathway for validated targets of significant miRNAs, and visualize the interactions among them. Using univariate Cox's model with clinical parameters, we found that two clinical parameters, tobacco use and clinical stage, and seven miRNAs were highly correlated with the survival status. Only using the expression level of miRNA signatures, the model could separate patients into high-risk and low-risk groups successfully. An optimal feature-selected model was proposed based on two clinical parameters and seven miRNAs. Functional analysis of these seven miRNAs showed they were associated to various pathways related to cancer, including MAPK, VEGF and P53 pathways. These results helped the research of identifying targets for targeted therapy which could potentially allow tailoring of treatment for cervical cancer patients.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学 3 区 细胞生物学
最新[2025]版:
JCR分区:
出版当年[2014]版:
Q1 ONCOLOGY Q1 CELL BIOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2014版] 出版当年五年平均 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者单位: [1]Wuhan Univ, Sch Publ Hlth, Wuhan 430071, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:2 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)